Chemoinformaics analysis of BETA-EUDESMOL ACETATE
Molecular Weight | 264.409 | nRot | 2 |
Heavy Atom Molecular Weight | 236.185 | nRig | 13 |
Exact Molecular Weight | 264.209 | nRing | 2 |
Solubility: LogS | -4.144 | nHRing | 0 |
Solubility: LogP | 4.66 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 47 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 17 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 48.6642 |
nHD | 0 | BPOL | 30.6938 |
QED | 0.542 |
Synth | 3.963 |
Natural Product Likeliness | 2.417 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.086 |
Pgp-sub | 0 |
HIA | 0.005 |
CACO-2 | -4.614 |
MDCK | 0.0000181 |
BBB | 0.955 |
PPB | 0.868742 |
VDSS | 1.332 |
FU | 0.15774 |
CYP1A2-inh | 0.155 |
CYP1A2-sub | 0.247 |
CYP2c19-inh | 0.198 |
CYP2c19-sub | 0.844 |
CYP2c9-inh | 0.292 |
CYP2c9-sub | 0.319 |
CYP2d6-inh | 0.024 |
CYP2d6-sub | 0.351 |
CYP3a4-inh | 0.209 |
CYP3a4-sub | 0.301 |
CL | 4.637 |
T12 | 0.16 |
hERG | 0.013 |
Ames | 0.008 |
ROA | 0.019 |
SkinSen | 0.127 |
Carcinogencity | 0.143 |
EI | 0.35 |
Respiratory | 0.943 |
NR-Aromatase | 0.011 |
Antiviral | Yes |
Prediction | 0.770255 |